Over the last 7 days, the Pharma industry has remained flat, although notably Eli Lilly declined by 3.3%. As for the the longer term, the industry is up 19% over the past 12 months. Looking forward, earnings are forecast to grow by 23% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | US$2.0t | US$356.5b | US$13.2b | 16.2x | 149.2x | 5.5x |
Sun, 23 Jun 2024 | US$2.0t | US$358.2b | US$14.1b | 16.5x | 139x | 5.5x |
Tue, 21 May 2024 | US$1.9t | US$358.3b | US$14.0b | 18.2x | 133.7x | 5.2x |
Thu, 18 Apr 2024 | US$1.8t | US$357.7b | US$29.9b | 20.4x | 59.9x | 5x |
Sat, 16 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 19.8x | 83x | 5.2x |
Mon, 12 Feb 2024 | US$1.9t | US$354.7b | US$22.8b | 31.7x | 81.6x | 5.2x |
Wed, 10 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 27.8x | 52.3x | 4.7x |
Fri, 08 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.7x | 49x | 4.4x |
Sun, 05 Nov 2023 | US$1.6t | US$376.9b | US$33.9b | 18.5x | 48.1x | 4.3x |
Tue, 03 Oct 2023 | US$1.6t | US$381.8b | US$43.8b | 19x | 37.7x | 4.3x |
Thu, 31 Aug 2023 | US$1.7t | US$381.4b | US$43.8b | 21.1x | 39.6x | 4.5x |
Sat, 29 Jul 2023 | US$1.7t | US$393.6b | US$61.5b | 18.5x | 27.8x | 4.3x |
Mon, 26 Jun 2023 | US$1.8t | US$392.8b | US$60.1b | 18.9x | 29.2x | 4.5x |
Wed, 24 May 2023 | US$1.7t | US$393.0b | US$60.5b | 18.5x | 28.2x | 4.3x |
Fri, 21 Apr 2023 | US$1.7t | US$402.6b | US$63.3b | 17.4x | 26.1x | 4.1x |
Sun, 19 Mar 2023 | US$1.5t | US$401.1b | US$69.3b | 15.5x | 22.2x | 3.8x |
Tue, 14 Feb 2023 | US$1.7t | US$401.8b | US$68.8b | 18.6x | 24.3x | 4.2x |
Thu, 12 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.4x | 24.5x | 4.3x |
Sat, 10 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.5x | 24.8x | 4.3x |
Mon, 07 Nov 2022 | US$1.7t | US$403.8b | US$71.4b | 14.3x | 23.5x | 4.2x |
Wed, 05 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 13.2x | 22.3x | 3.9x |
Fri, 02 Sep 2022 | US$1.6t | US$403.1b | US$70.2b | 14.5x | 22.6x | 3.9x |
Sun, 31 Jul 2022 | US$1.7t | US$405.2b | US$69.8b | 21.5x | 23.9x | 4.1x |
Tue, 28 Jun 2022 | US$1.7t | US$392.6b | US$64.9b | 22.2x | 26.5x | 4.4x |
Thu, 26 May 2022 | US$1.7t | US$392.5b | US$64.7b | 21x | 26.1x | 4.3x |
Sat, 23 Apr 2022 | US$1.6t | US$374.9b | US$59.9b | 21.4x | 27.2x | 4.3x |
Mon, 21 Mar 2022 | US$1.6t | US$373.7b | US$60.2b | 20.6x | 27.4x | 4.4x |
Wed, 16 Feb 2022 | US$1.6t | US$377.2b | US$55.4b | 21.4x | 28.1x | 4.1x |
Fri, 14 Jan 2022 | US$1.6t | US$361.3b | US$37.8b | 24.3x | 42.6x | 4.5x |
Sun, 12 Dec 2021 | US$1.5t | US$361.1b | US$38.1b | 21.7x | 40.6x | 4.3x |
Tue, 09 Nov 2021 | US$1.6t | US$358.7b | US$38.6b | 24.3x | 41.2x | 4.4x |
Thu, 07 Oct 2021 | US$1.5t | US$337.7b | US$24.9b | 19.3x | 59.7x | 4.4x |
Sat, 04 Sep 2021 | US$1.6t | US$338.5b | US$25.8b | 20.6x | 61.6x | 4.7x |
Mon, 02 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20x | 60.3x | 4.6x |
60.3x
How does U.S. Pharma compare with similar industries?
US Market | -2.42% | |
Healthcare | 1.13% | |
Pharma | 0.0036% | |
Pharma | 0.0036% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
BMY Bristol-Myers Squibb | US$50.45 | 18.3% +US$15.8b | -17.8% | PS2.2x | |
JNJ Johnson & Johnson | US$160.64 | 3.8% +US$14.4b | -7.9% | PE23.6x | |
PFE Pfizer | US$30.77 | 2.7% +US$4.5b | -14.7% | PS3.2x | |
ITCI Intra-Cellular Therapies | US$80.39 | 7.4% +US$583.8m | 32.2% | PS16.5x | |
ZTS Zoetis | US$179.84 | 0.7% +US$574.9m | -5.3% | PE34.3x |